Day: April 10, 2026

Fluxys Belgium – Regulated information: Ordinary General Meeting on 12 May 2026

Written by Customer Service on April 10, 2026. Posted in Public Companies.

The Board of directors of Fluxys Belgium SA has the honour to invite the shareholders of the company to attend the Ordinary General Meeting to be held on Tuesday 12 May 2026 as from 2.30 pm at the BNP Event Center, Rue Royale 20, 1040 Brussels. Please find enclosed the notice of this General Meeting (in Dutch or French). The other documents related to this General Meeting, as well as the integrated annual report 2025, are available on the Fluxys Belgium website.AttachmentsBijlage 1 – BijeenroepingAnnexe 1 – Convocation

NexLiving Communities Reports Record Q4 2025 Results and Announces Promotion of Ahmed Shethwala to Chief Financial Officer

Written by Customer Service on April 10, 2026. Posted in Earnings Releases And Operating Results.

HALIFAX, Nova Scotia, April 10, 2026 (GLOBE NEWSWIRE) — (TSXV: NXLV) – NexLiving Communities Inc. (“NexLiving” or the “Company”) announced operating and financial results for the three months and year ended December 31, 2025. Stavro Stathonikos, President & CEO commented: “Q4 capped a record year for NexLiving, with 53% growth in cash flow per share driven by the internalization of our operations and integration of acquisitions. With that work largely complete, we enter 2026 with an efficient, technology-enabled platform and a stronger base of free cash flow. Our focus this year is on unlocking value across the existing portfolio and deploying capital into accretive acquisitions to continue to compound value for our shareholders.” Summary of Results:Net operating income (“NOI”) increased by +7% to $5.3 million for the three-month...

NeurAxis, Inc. Announces Preferred Stock Dividend

Written by Customer Service on April 10, 2026. Posted in Dividend Reports And Estimates.

CARMEL, Ind., April 10, 2026 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced that on April 10, 2026, its Board of Directors declared a dividend on its Series B Preferred Stock. Holders of record of the Company’s Series B Preferred Stock (the “Series B Preferred Stock”) as of the close of business on April 21, 2026 will receive a stock dividend of the Company’s common stock, par value $0.001 per share (the “Common Stock”), for every one share of Series B Preferred Stock held. The number of shares of Common Stock to be received by each holder will be determined based on the accrued and unpaid dividends on such holder’s Series B Preferred Stock...

Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting

Written by Customer Service on April 10, 2026. Posted in Public Companies.

Oral presentations feature phentolamine ophthalmic solution 0.75% RESEARCH TRIANGLE PARK, N.C., April 10, 2026 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), today announced that three abstracts will be presented at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting in Washington, D.C., April 10-13, 2026. The presentations will include data across key areas of ophthalmology, including full results from VEGA-3, a Phase 3 study evaluating phentolamine ophthalmic solution 0.75% for presbyopia, and a post-hoc analysis of MIRA-2, a Phase 3 study evaluating the optical impact of RYZUMVI® for reversing pharmacologically-induced...

MTY Reports First Quarter Results for Fiscal 2026

Written by Customer Service on April 10, 2026. Posted in Earnings Releases And Operating Results.

GAAP Measures:Segment profits increased by 2% to reach $59.8 million during the quarter. Net income attributable to owners increased to $36.9 million, or $1.62 per diluted share compared to $1.7 million, or $0.07 per diluted share in Q1-25. Cash flows provided by operating activities of $40.9 million compared to $64.6 million in Q1-25, a change of $23.7 million. Long-term debt repayments $17.7 million more than doubled compared to the period in the prior year.Management Key Performance Indicators:Normalized adjusted EBITDA(1) remained steady at $60.1 million in the quarter, compared to $60.2 million in Q1-25. Adjusted earnings per share(1) of $0.98 per diluted share, an increase of 13% compared to $0.87 in Q1-25. Free cash flows net of lease payments(2) were $29.0 million or $1.27 per diluted share. System sales(3) were $1.3 billion...

Man Group PLC : Form 8.3 – Gamma Communications Plc

Written by Customer Service on April 10, 2026. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Gamma Communications plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening...

Agfa-Gevaert: Convening of Annual General Meeting

Written by Customer Service on April 10, 2026. Posted in Public Companies.

April 10, 2026 Regulated information Agfa-Gevaert: Convening of Annual General Meeting Mortsel, Belgium – April 10, 2026 Unofficial translation from the Dutch version AGFA-GEVAERTNAAMLOZE VENNOOTSCHAP [LIMITED LIABILITY COMPANY]SEPTESTRAAT 27B-2640 MORTSELENTERPRISE NUMBER 0404 021 727 INVITATION TO THE ANNUAL GENERAL MEETING The Board of Directors hereby cordially invites the shareholders to participate in the Annual General Meeting of the Company which will be held on Tuesday, May 12, 2026 at 11 a.m. at the registered office, B-2640 Mortsel, Septestraat 27. The Annual General Meeting has the following agenda: 1. Acknowledgement of the Annual Report of the Board of Directors and report of the Statutory Auditor regarding the statutory accounts and the consolidated accounts as per December...

HEINEKEN sells Bralima in the Democratic Republic of Congo and establishes long-term brand partnership

Written by Customer Service on April 10, 2026. Posted in Mergers And Acquisitions.

HEINEKEN sells Bralima in the Democratic Republic of Congo and establishes long-term brand partnership AMSTERDAM, 10th April 2026: HEINEKEN today announces that it has sold its shareholding in Brasseries, Limonaderies et Malteries S.A. (“Bralima”) its operating company in the Democratic Republic of Congo (“DRC”) to ELNA Holdings Ltd. The new owner will assume full responsibility for Bralima’s operations, including production, distribution, employees and engagement with local stakeholders. The transaction enables continuity of the business, supports local employment and ensures the long-term availability of HEINEKEN’s brands in the DRC. HEINEKEN will retain ownership of its global and regional brands and will continue to be present in the DRC through long-term trademark licensing agreements. These agreements will ensure the continued brewing,...

21shares Solidifies European Leadership with Strategic Expansion on Xetra

Written by Customer Service on April 10, 2026. Posted in Public Companies.

New listings meet surging demand for diversified and transparent crypto exposure in Germany Zurich, April 10th, 2026 – 21shares, one of the world’s largest issuers of cryptocurrency exchange-traded products (ETPs), today announced the cross-listing of nine additional products on Xetra. This expansion reinforces 21shares’ commitment to the German market, where it already holds a leading position on Xetra with a 26% market share. The newly listed products on Xetra include:21shares Sui Staking ETP (Ticker: 21SI GY) 21shares Hyperliquid ETP (Ticker: 21HY GY) 21shares Dogecoin ETP (Ticker: DOGE GY) 21shares Toncoin Staking ETP (Ticker: 2TON GY) 21shares Ondo ETP (Ticker: 21ON GY) 21shares Hedera ETP (Ticker: HDRA GY) 21shares Jito Staked SOL ETP (Ticker: 21JS GY) 21shares Pyth Network ETP (Ticker: PYTH GY) 21shares Strategy Yield ETP...

The consolidated sales of VILVI Group March 2026

Written by Customer Service on April 10, 2026. Posted in Public Companies.

VILVI Group, which consists of Vilkyškių pieninė AB, Modest AB, Kelmės pieninė AB, Kelmės pienas UAB, Pieno logistika AB, Baltic Dairy Board SIA and Marijampolės pieno konservai UAB, which joined the Group on 16 January 2026, consolidated sales for March 2026 amounted EUR 33.85 million – 45.5% increase comparing to March 2025. The consolidated sales of the Group for period January – March 2026 amounted to EUR 86.31 million – 21.5% increase comparing to the same period last year. Vilija MilaseviciuteEconomics and finance directorPhone: +370 441 55 102 Email: vilija.milaseviciute@vilvi.eu

Day: April 10, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals